New guidelines shift focus away from metformin as first-line treatment for type 2 diabetes

The American Diabetes Association and the European Association for the Study of Diabetes have revised their joint guidelines, moving away from metformin as the default initial therapy for type 2 diabetes towards personalised treatment options including SGLT2 and GLP-1 therapies,…













